about
Review article: effect of bile salt pool composition on hepatic and biliary functions.Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.Management of bone disease in Gaucher disease type 1: clinical practice.Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease.Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line.Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans.Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo.Nonalcoholic fatty liver disease induced by leuprorelin acetate.Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study.Short-term multidisciplinary non-pharmacological intervention is effective in reducing liver fat content assessed non-invasively in patients with nonalcoholic fatty liver disease (NAFLD).Prevalence rates of gallstone disease in Italy. The Chianciano population study.Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years.Effect of liver cirrhosis on the systemic availability of naltrexone in humansEffects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver diseaseTu-P8:328 Molecular regulation of sterol metabolism by bile acids in cultured human hepatocytesW15-P-001 Role of nuclear receptors in the molecular regulation of cholesterol homeostasis in cultured human hepatocytesExtent of bile acid-induced hepatic damage dictates activin a secretion in HepG2 cellsEffect of diabetic autonomic neuropathy on gall bladder kinetics in insulin-dependent diabetic patientsMinimal disease activity in Gaucher disease: criteria for definitionHerpesvirus DNA is frequently detected in liver tissue from hepatitis C patientsErratum to: Management of Bone Disease in Gaucher Disease Type 1: Clinical PracticeCholesterol esterase activity of human intestinal mucosa
P50
Q33973598-747866EB-7B5A-44CA-8CBD-9C2629C9603FQ38176690-2A001833-3766-42E3-B7C7-C10CCFC28423Q38290826-57D596CF-BF2A-434F-920B-ADD1CDEC330DQ39007048-3B042BA6-D7FD-4A59-AD15-D47F44599F89Q40741563-CEC011D4-574A-45C6-8A6A-F3C161E16241Q43693260-B0830956-2194-41DF-8EA7-6644EAEDBD59Q44280532-3AE35D89-8DF0-4DA4-BFFA-315635386A53Q46838039-0E2DA0A9-1B23-462E-9883-2580BA46C51FQ47801980-80CD477C-AC68-4464-AEB2-61966A078198Q50111418-0AB6DF05-B1E3-465E-934D-0444FEE29913Q50183264-A449CCBB-9A94-4199-AEF5-95EBE7914D83Q50790826-CB83CA75-A649-4407-A335-EDE6F3045488Q58896381-32A59CC2-C347-4AC1-9731-861B6921DD7DQ61249101-2AE6845F-D6F2-4DA3-A8C8-B6847026B28CQ61854239-3365F9D3-B63D-4328-8882-769E2D254E54Q61854255-930D94B7-5927-4B87-92AB-6CB11F1387BDQ61854298-F44C16BF-78FD-48A7-AA4E-408C89F736C7Q61854334-18679F05-C4F2-4A2A-AE17-A85865040A29Q64039929-9B9305D2-A0A1-44AF-962D-DF1CAC3B1EDBQ73148567-E93BD031-7617-4EC6-9CB9-FB4C8F40779EQ87046594-686C0302-A911-426E-B6C7-43937399EBCEQ93631191-9BC3340E-B745-4D3D-82F5-9D10B3AB63B3
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7504-6407
@en
name
F Carubbi
@ast
F Carubbi
@en
F Carubbi
@es
F Carubbi
@nl
type
label
F Carubbi
@ast
F Carubbi
@en
F Carubbi
@es
F Carubbi
@nl
prefLabel
F Carubbi
@ast
F Carubbi
@en
F Carubbi
@es
F Carubbi
@nl
P106
P1153
6603040572
P31
P496
0000-0001-7504-6407